Jan 31 (Reuters) - Prana Biotechnology Ltd (PBT) : PRANA BIOTECHNOLOGY-US FOOD AND DRUG ADMINISTRATION GRANTED ORPHAN DRUG DESIGNATION FOR LEAD MOLECULE PBT434 FOR TREATMENT OF MULTIPLE SYSTEM ATROPHY
ASX Market Open: Aussie market to leap on best 'Trump trade' bump since election day | November 22, 2024